Skip to main content
Signal8

Johnson Shane Aaron

SEC insider (Form 3/4/5 filer). CIK 0001889332. Sr VP & General Manager at InMed Pharmaceuticals Inc. (INM). 2 reported Form 4/5 transactions since Sep 2024; latest on Dec 19, 2025. Located in VANCOUVER, A1.

Companies Johnson Shane Aaron has filed insider reports for

  • InMed Pharmaceuticals Inc. (INM): Officer, Sr VP & General Manager
Johnson Shane Aaron profile photo

Johnson Shane Aaron

CIK: 0001889332

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

InMed Pharmaceuticals Inc. logo
INM

InMed Pharmaceuticals Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • InMed Pharmaceuticals Inc. logo
    INM

    InMed Pharmaceuticals Inc.

    Dec 19, 2025
    Award

    Employee Stock Option (Right to Buy)

    Direct
    8.5K shares-
  • InMed Pharmaceuticals Inc. logo
    INM

    InMed Pharmaceuticals Inc.

    Dec 20, 2024
    Award

    Employee Stock Option (Right to Buy)

    Direct
    1.5K shares-

1-2 of 2